Trial Profile
An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetics After Administration of CJ30001 and Co-administration of HKB0701/SLM0807 in Korean Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Metformin/voglibose (Primary) ; Voglibose (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors CJ Corporation; HK inno.N
- 04 Sep 2018 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
- 14 Jun 2011 New trial record